A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Public ClinicalTrials.gov record NCT07525375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, 3-Period Cross-over, Dose-ranging Study to Assess the Efficacy and Safety of Glycopyrronium (GP) Versus Placebo in Participants of 4 to Less Than 12 Years of Age With Asthma Receiving Background Budesonide and Formoterol Fumarate (BFF)
Study identification
- NCT ID
- NCT07525375
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Interventions
- BFF MDI Combination Product
- GP MDI Combination Product
- Placebo MDI Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 4 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2026
- Primary completion
- May 22, 2029
- Completion
- May 22, 2029
- Last update posted
- Apr 21, 2026
2026 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Bakersfield | California | 93301 | Not yet recruiting |
| Research Site | Long Beach | California | 90806 | Not yet recruiting |
| Research Site | San Diego | California | 92123 | Not yet recruiting |
| Research Site | Miami | Florida | 33125 | Not yet recruiting |
| Research Site | Pembroke Pines | Florida | 33026 | Not yet recruiting |
| Research Site | Owensboro | Kentucky | 42301 | Recruiting |
| Research Site | Lafayette | Louisiana | 70508 | Not yet recruiting |
| Research Site | Boston | Massachusetts | 02114 | Not yet recruiting |
| Research Site | Columbia | Missouri | 65203 | Not yet recruiting |
| Research Site | Cincinnati | Ohio | 45229 | Not yet recruiting |
| Research Site | Oklahoma City | Oklahoma | 73120 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07525375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07525375 live on ClinicalTrials.gov.